Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Mutation research

• Publication date

  1993-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/0027-5107(93)90006-2PMID 7678907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature

  1991cited by this paper
• The weight of the evidence among group C carcinogens.

  1991cited by this paper
• Scientific concepts, value, and significance of chemical carcinogenesis studies.

  1991cited by this paper
• Genetic errors, cell proliferation, and carcinogenesis.

  1991cited by this paper
• Detection of human carcinogens

  1991cited by this paper
• Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP.

  1991cited by this paper
• Genetic regulation of mammary carcinogenesis in the rat by susceptibility and suppressor genes.

  1991cited by this paper
• Chemical carcinogenesis: too many rodent carcinogens.

  1990cited by this paper
• A scheme for classifying carcinogens.

  1990cited by this paper
• Carcinogenicity results for 114 laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity

  1990cited by this paper
• Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests.

  1990cited by this paper
• International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.

  1990cited by this paper
• Prediction of risk for human developmental toxicity: How important are animal studies for hazard identification?

  1989cited by this paper
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr

  1989cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• The genetic toxicity of human carcinogens and its implications.

  1988cited by this paper
• Extrapolation of the relative risk of radiogenic neoplasms across mouse strains and to man.

  1988cited by this paper
• Information value of the rodent bioassay

  1988cited by this paper
• Potential role of alpha-2 mu-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane.

  1988cited by this paper
• Ranking possible carcinogenic hazards.

  1987cited by this paper
• Activation of the K-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane.

  1987cited by this paper
• Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice.

  1986cited by this paper
• Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N X C3H/HeN)F1 (B6C3F1) mice.

  1985cited by this paper
• Ranking animal carcinogens: a proposed regulatory approach.

  1981cited by this paper
• A Dominant Gene for Renal Adenomas in the Rat

  1961cited by this paper

• Origin Story of IARC's 10 Key Characteristics of Carcinogens

  2025cites this paper
• Pheochromocytoma in rats: a weak link in the assessment of talc carcinogenicity?

  2025cites this paper
• EMA commentary on the ICH guideline for testing for carcinogenicity of pharmaceuticals

  2023cites this paper
• The codification of hazard and its impact on the hazard versus risk controversy

  2021cites this paper
• In silico scaling and prioritization of chemical disposition and chemical toxicity of 15,145 organic chemicals

  2019cites this paper
• An integrative test strategy for cancer hazard identification

  2016cites this paper
• Toward More Scientific Relevance in Carcinogenicity Testing

  2013cites this paper
• The Salmonella Mutagenicity Assay: The Stethoscope of Genetic Toxicology for the 21st Century

  2010cites this paper
• Evaluation of In vitro Assays for Assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco

  2009cites this paper
• Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action–Based Predictions of Chemical Carcinogenesis in Rodents

  2008cites this paper
• An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide

  2008cites this paper
• Toxicity Data Informatics: Supporting a New Paradigm for Toxicity Prediction

  2008cites this paper
• A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database.

  2007cites this paper
• Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models.

  2007cites this paper
• Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research.

  2007cites this paper
• A mechanism-based cancer risk assessment for 1,4-dichlorobenzene.

  2007cites this paper
• 5.23 – Electrotopological State Indices to Assess Molecular and Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties

  2007cites this paper
• A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.

  2006cites this paper
• An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.

  2006cites this paper
• Computer-aided rodent carcinogenicity prediction.

  2005cites this paper
• The second National Toxicology Program comparative exercise on the prediction of rodent carcinogenicity: definitive results.

  2004cites this paper
• Transgenic mice as alternatives in carcinogenicity testing: current status

  2004cites this paper
• A Structure‐Information Approach to the Prediction of Biological Activities and Properties

  2004cites this paper
• Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices.

  2003cites this paper
• Reshaping the carcinogenic risk assessment of medicines: international harmonisation for drug safety, industry/regulator efficiency or both?

  2003cites this paper
• Die biologische Wirkung von Monomeren zahnärztlicher Komposite: Charakterisierung induzierter Genmutationen in vitro und molekulare Analyse HPRT-defizienter V79-Zellen

  2002cites this paper
• The role of transgenic mouse models in carcinogen identification.

  2002cites this paper
• Mutational specificity of environmental carcinogens

  2002cites this paper
• Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens

  2002cites this paper
• AI and SAR approaches for predicting chemical carcinogenicity: Survey and status report

  2002cites this paper
• Alternatives Models in Carcinogenicity Testing—A European Perspective

  2002cites this paper
• Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.

  2001cites this paper
• Genetic Toxicity Tests for Predicting Carcinogenicity

  2001cites this paper
• The Nature of the Heterozygous Trp53 Knockout Model for Identifi cation of Mutagenic Carcinogens

  2001cites this paper
• Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.

  2000cites this paper
• Use of toxicological information in drug design.

  2000cites this paper
• Current status and use of short/medium-term models for assessment of carcinogenicity of human pharmaceuticals: regulatory perspectives.

  2000cites this paper
• Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.

  2000cites this paper
• Current status and use of short/medium-term models for assessment of carcinogenicity of human pharmaceuticals: regulatory perspectives.

  2000cites this paper
• Morphological transformation and effect on gap junction intercellular communication in Syrian hamster embryo cells as screening tests for carcinogens devoid of mutagenic activity.

  2000cites this paper
• Prediction of Chemical Carcinogenicity in Rodents By Machine Learning of Decision Trees and Rule Sets

  1999cites this paper
• Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis

  1999cites this paper
• Genetically altered mouse models for identifying carcinogens.

  1999cites this paper
• Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice.

  1999cites this paper
• Use of Syrian hamster embryo and BALB/c 3T3 cell transformation for assessing the carcinogenic potential of chemicals.

  1999cites this paper
• Species differences in chemical carcinogenesis of the thyroid gland, kidney and urinary bladder.

  1999cites this paper
• Evaluation and validation issues in the development of transgenic mouse carcinogenicity bioassays.

  1998cites this paper
• The traditional toxicologic paradigm is correct: dose influences mechanism.

  1998cites this paper
• New perspectives for alternative approaches to carcinogenicity testing: a regulator viewpoint.

  1998cites this paper
• Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.

  1998cites this paper
• Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.

  1998cites this paper
• A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software.

  1998cites this paper
• Molecular Genetics of Renal Carcinogenesis

  1998cites this paper
• Validation of transgenic mice harboring the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.

  1998cites this paper
• New perspectives for alternative approaches to carcinogenicity testing: a regulator viewpoint.

  1998cites this paper
• In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.

  1998cites this paper
• Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studies.

  1997cites this paper
• The first US National Toxicology Program exercise on the prediction of rodent carcinogenicity: definitive results.

  1997cites this paper
• The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe.

  1997cites this paper
• Activity profiles of carcinogenicity data: application in hazard identification and risk assessment.

  1997cites this paper
• Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals.

  1997cites this paper
• Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene.

  1997cites this paper
• T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity.

  1997cites this paper
• Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.

  1997cites this paper
• Potency grading in carcinogen classification

  1997cites this paper
• The low pH Syrian hamster embryo (SHE) cell transformation assay: a revitalized role in carcinogen prediction.

  1996cites this paper
• Genetic toxicology and risk assessment of complex environmental mixtures.

  1996cites this paper
• A computerized connectivity approach for analyzing the structural basis of mutagenicity in Salmonella and its relationship with rodent carcinogenicity

  1996cites this paper
• Speculations on the rodent carcinogenicity of 30 chemicals currently under evaluation in rat and mouse bioassays organised by the U.S. National Toxicology Program

  1996cites this paper
• Risk assessment and the use of information on underlying biologic mechanisms: a perspective.

  1996cites this paper
• EMF and current cancer concepts.

  1996cites this paper
• Carcinogens in food: priorities for regulatory action

  1996cites this paper
• Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus

  1996cites this paper
• 3 Carcinogenicity

  1996cites this paper
• The QSAR and Modelling Society

  1996cites this paper
• Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents?

  1996cites this paper
• Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens.

  1996cites this paper
• Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.

  1995cites this paper
• Mechanisms of Toxicity and Carcinogenesis

  1995cites this paper
• The carcinogenesis bioassay in perspective: application in identifying human cancer hazards.

  1995cites this paper
• Marketed Human Pharmaceuticals Reported to be Tumorigenic in Rodents

  1995cites this paper
• Use of a multistrain assay could improve the NTP carcinogenesis bioassay.

  1995cites this paper
• Transgenic technology in biomedicine and toxicology

  1995cites this paper
• Summary and recommendations for session B: activity classification and structure-activity relationship modeling for human health risk assessment of toxic substances.

  1995cites this paper
• Expression of Exposure in Negative Carcinogenicity Studies: Dose/Body Weight, Dose/Body Surface Area, or Plasma Concentrations?

  1995cites this paper
• The Tenth Aspen Cancer Conference. Mechanisms of Toxicity and Carcinogenesis. July 15-20, 1995, Aspen, Colorado. Abstracts.

  1995cites this paper
• The case for an upper dose limit of 1000 mg/kg in rodent carcinogenicity tests.

  1995cites this paper
• Nongenotoxic Chemical Carcinogens: Evidence for Multiple Mechanisms

  1994cites this paper
• Gene manipulation and genetic toxicology.

  1994cites this paper
• Transgenic animals in toxicology.

  1994cites this paper
• Prediction of rodent carcinogenicity for 44 chemicals: results.

  1994cites this paper
• Relationship between molecular connectivity and carcinogenic activity: a confirmation with a new software program based on graph theory.

  1993cites this paper
• Will all chemicals be carcinogenic to rodents when adequately evaluated?

  1993cites this paper
• High dose levels are not necessary in rodent studies to detect human carcinogens.

  1993cites this paper
• The Induction of Rules for Predicting Chemical Carcinogenesis in Rodents

  1993cites this paper